Keynote presentation

Spotlight on AMR and Infection management - Global issues

Impact of AMR in challenging populations

Improving antimicrobial prescribing in children

The importance of time to appropriate antibiotic therapy

Resistance game changers and challenges

AMR and big data: the art of the possible

Drugs, devices and diagnostics - the new frontiers

Hot topics

Clinical quandaries - case based presentations on global challenges

Antimicrobial challenges

Panel discussion

Shortages, stockouts and scarcity: The issues facing the security of antibiotic supply and the role for pharmaceutical companies

Dr Deidre Cogan, Writer/Editor, Access to Medicine Foundation

The link between social and economic deprivation and AMR - via Skype

Professor Ramanan Laxminarayan, Director and Senior Fellow, The Center for Disease Dynamics, Economics & Policy, Washington DC

Innovation and AMR

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Tailoring stewardship to context: Drivers and patterns of antibiotic prescribing and consumption in rural China

Professor Helen Lambert, Professor of Medical Anthropology, Bristol Medical School, University of Bristol

UK Initiatives to Reduce Inappropriate Antibiotic Prescribing

Professor Alan Johnson, Head of Surveillance in the Healthcare-Associated Infection & Antimicrobial Resistance (HCAI & AMR) Division of the National Infection Service, Public Health England

Bacteriophages - how significant will their impact be?

Professor Martha Clokie, Professor of Microbiology, University of Leicester

It all gone to worms - the role of odilorhabdins!

Dr Philippe Villain-Guillot, CEO, Nosopharm

Role of digital PCR in high accuracy measurement in infectious diseases

Dr Denise O’Sullivan, Science Leader, LGC

Inter-laboratory study comparing bacterial AMR predictions from WGS data

Dr Ronan Doyle, Research Associate, Great Ormond Street Hospital NHS Foundation Trust

Developing metrology to support antimicrobial discovery, validation and screening

Professor Max Ryadnov, Biometrology Leader, National Physical Laboratory

Standardisation of procalcitonin measurement

Dr Amandine Boeuf, Researcher, Laboratoire de Métrologie et d’Essai (LNE)

Life after a MDR GNB Outbreak - Treatment pathway change in Manchester and emerging data

Dr Louise Sweeney, Central Manchester University Hospitals NHS Trust

Garrod Lecture 2019: MDR efflux in Gram negative bacteria - how understanding resistance led to a new tool for drug discovery

Professor Laura Piddock, University of Birmingham and GARDP

Global Knowledge exchange - Antimicrobial Resistance and Stewardship

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Stewardship

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Diagnostics

Dr Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, Deputy Head of Division of Infection and Pathway Medicine, University of Edinburgh

Behaviour Change & AMR

Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London

Managing self-limiting infections in community pharmacies: a cluster randomised controlled trial

Ms Eno Umoh, Public Health England

Ceftazidime/avibactam in paediatrics: Challenges and treatment outcomes

Mrs Frances Garraghan, Lead antimicrobial pharmacist, Manchester University Foundation Trust

Educating the workforce in AMR – too many gimmicks or coming up trumps?

Dr Angharad Davies, Clinical Associate Professor, Swansea University Medical School

Why do dentists prescribe antibiotics for adults with toothache or infection?

Mrs Wendy Thompson, University of Leeds

Structuring the Management of High-Risk Skin Infections: A Model Care Pathway

Dr Abid Hussain, University Hospitals of Birmingham NHS Foundation Trust

Current and future directions for rapid AMR diagnostics

Dr Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, Deputy Head of Division of Infection and Pathway Medicine, University of Edinburgh

MALDI-TOF-MS - beyond species ID

Dr Belén Rodriguez Sanchez, Hospital Gregorio Maranon, Madrid

AMR detection in the WGS era

Professor John Rossen, Medical Molecular Microbiologist, University of Groningen, The Netherlands

Antimicrobial resistance: how journalism can help

Ms Madlen Davies, Health and science editor, The Bureau of Investigative Journalism

Public perception of antimicrobials and AMR – how it is shaped and informed

Dr Laurie Denyer Willis, Research Fellow, London School of Hygiene and Tropical Medicine

Public health driven R&D of antibiotics for priority drug resistant infections

Dr Seamus O'Brien, R&D Director, Global Antibiotic R&D Partnership (GARDP)

CARB-X: Building A Portfolio of New Antibiotics, Vaccines & Diagnostics with Open Science

Dr Richard Lawson, Director of the CARB-X Program Management Office

Swab and send – discovering new antimicrobials from natural products

Dr Adam Roberts, Senior lecturer, Liverpool School of tropical Medicine

What's new in conjugate vaccine development against infectious disease

Dr Viliam Pavliak, Senior Advisor, International Vaccine Institute

The global roadmap for STI vaccine development - state of the art review

Dr David McIntosh, Honorary Clinical Senior Lecturer, Imperial College London

The of Role of Vaccines in Preventing AMR

Dr Rajeka Lazarus, Consultant in Microbiology and Infectious Diseases, Bristol

Conservation of antibiotics is the ONLY way forward

Heterogencity: A little bit of everything will work wonders - cycling antibiotics is the future!

Welcome and Opening Remarks

Professor Dilip Nathwani OBE

Global epidemiology of infectious diseases and AMR and the role of informatics

Professor Michael Osterholm

Global burden of bacterial infections: the role of vaccines in reducing AMR

Dr David McIntosh

Enabling the adoption of new diagnostics within the UK healthcare system

Dr Fiona Carragher

Stewardship in Kerala, India

Dr Sanjeev Singh

Experiences from Latin America

Dr Gabriel Levy Hara

Stewardship in Africa - challenges and opportunities

Dr Brian Godman

Diagnostic testing for point of care C Reactive Protein and how it can guide antibiotic prescribing

Supported by Abbott

Technology overview - The Accelerate Pheno™ System

Steve Holland

Clinical Experiences of the Accelerate Pheno™ System at an NHS District General Hospital

Dr Claire Thomas

What surveillance do we have for AMR?

Dr Berit Muller-Peabody

Why is surveillance important after introducing vaccines?

Dr Michael Edelstein

Rapid surveillance in emergency situations: The Zika Experience

Professor Jimmy Whitworth

Legacy planning – what did we learn from Ebola

Dr Timothy Brooks

Procalcitonin – lessons and limitations

Dr Stephan Harbarth

MALDI-TOF and its impact on patient care

Dr Savita Gossain

Syndromic approaches to infection detection - TaqMan array cards

Dr Martin Curran

Alternative models of care: Nurses in antimicrobial stewardship

Jo McEwen

Successful stewardship in hospital settings (HDU and general)

Dr Charles Luyt

Antimicrobial stewardship in long term care facilities (LTCFs)

Dr Elizabeth Beech

Global Antimicrobial Resistance Surveillance System (GLASS)

Professor Roman Kozlov

Global PPS

Professor Herman Goossens

New Vaccines against Epidemic Infectious Diseases

Dr David McIntosh

New for old and emerging treatments - a summary of new agents in development

Professor Alasdair MacGowan

Clinical need for rapid diagnostic tests

Professor Herman Goossens

Skin patch antibiotics - the next big thing?

Professor Ryan Donnelly

Harnessing the host-protein response to distinguish between bacterial and viral infections

Dr Liran Shani

Lefamulin: the potential for one antibiotic rather than two in CABP

Professor Mark Wilcox

Rapid susceptibility testing: new phenotypic and non-WGS genotypic approaches

Dr Oskar Ekelund

WGS-based susceptibility testing for TB: from research to service delivery

Professor Grace Smith

Should WGS be used for susceptibility testing of bacteria other than TB?

Dr Matthew Ellington

Preparing for the Black Swans of resistance

Professor David Livermore

Progressing the new essential medicines agenda

Professor Celine Pulcini

Use of reporting guidelines to design, report and referee antibiotic stewardship studies

Dr Sheldon Stone

Latest clinical data and early experience of managing difficult-to-treat Gram-negative infections with a novel β-lactamase inhibitor combination

Supported by Pfizer

Current thinking about cephalosporins and CDI & AMR. Can a new cephalosporin help?

Supported by Cardiome

Delivering open access, high impact-low cost education to all

Professor Dilip Nathwani OBE

Developing a global community of practice

Dr Elizabeth Tayler

Welcome

Professor Dilip Nathwani OBE, President, BSAC

The current global and UK epidemiology of GNB infections

Professor Timothy Walsh, Professor of Medical Microbiology and Antibiotic Resistance, Cardiff University

Burden and current global management on GNB infections: Lessons from a global PPS

Dr Ann Versporten, Global PPS Coordination Centre, University of Antwerp, Antwerp

Clinical presentations and impact of GNB infections in the UK

Dr Gavin Barlow, Infectious Diseases Consultant, Hull & East Yorkshire Hospitals NHS Trust

Hospital antibiotic prescribing to minimise AMR - the Antibiotic Reduction Kit (ARK-Hospital) Programme

Professor Martin Llewelyn, Reader in Infectious Diseases, Brighton and Sussex Medical School

NDM, ESBL and KPC - the US experience

Dr Lilian Abbo, Chief Infection Prevention & Antimicrobial Stewardship JHS President WIAM Advisory Board UMMSM, Jackson Health System, University of Miami, United States

UK Guidelines for GNB infections

Professor Peter Hawkey, PHE Lead Public Health Microbiologist, Heart of England NHS Foundation Trust, Birmingham UK

Optimising PK/PD for treatment of GNB

Dr Federico Pea, Institute of Clinical Pharmacology, University Teaching Hospital of Udine, Italy

A randomised controlled trial evaluating the TARGET (Treat Antibiotics Responsibly, Guidance, Education, Tools) Antibiotics toolkit

Miss Leah Jones, Trainee Health Psychologist & Research Assistant, Public Health England

Rapid phenotypic susceptibility testing of bacteria: SLIC by name and slick by nature

Dr Robert Hammond, Post Doctoral Research Fellow, University of St Andrews

Quality indicators and quantity metrics for responsible antibiotic use, lessons from DRIVE-AB

Dr Vera Vlahović-Palčevski, Clinical Pharmacologist, DRIVE-AB & University of Rijeka, Croatia

UK approach to use of metrics and targets for GNB infections

Dr Susan Hopkins, Consultant in Infectious Diseases & Microbiology, Royal Free Hospital, NHS Trust, London

GNB infections and stewardship

Professor Dilip Nathwani OBE, Consultant Physician and Honorary Professor of Infection, University of Dundee, Dundee UK

Prevention of GNB infections

Professor Peter Wilson, Consultant Microbiologist, UCHL Foundation NHS Trust, London

Drug discovery to combat GNB infections: current challenges and possible progress

Professor Mike Ferguson, Regius Professor and Associate Dean for Research Strategy, Biologicial Chemistry and Drug Discovery, University of Dundee, Dundee UK

BSAC AGM

Professor Dilip Nathwani OBE, President, BSAC

BSAC Virtual Learning Environment

Professor Dilip Nathwani OBE, President, BSAC & Mr Mark Lester, FutureLearn